Non-Thermal Plasma as a Novel Strategy for Treating or Preventing Viral Infection and Associated Disease

• Published in: Frontiers in physics Vol. 9
• Main Authors: Mohamed, Hager, Nayak, Gaurav, Rendine, Nicole, Wigdahl, Brian, Krebs, Fred C., Bruggeman, Peter J., Miller, Vandana
• Format: Journal Article
• Language: English
• Published: United States Frontiers Research Foundation 01.06.2021; Frontiers Media S.A
• Subjects: 60 APPLIED LIFE SCIENCES; adjuvant; antiviral; disinfection; immunotherapy; reactive oxygen and nitrogen species; SARS-CoV-2; vaccine; virus inactivation
• ISSN: 2296-424X; 2296-424X
• DOI: 10.3389/fphy.2021.683118

Pathogenic viruses cause many human, animal, and plant diseases that are associated with substantial morbidity, mortality and socio-economic impact. Although effective strategies for combatting virus transmission and associated disease are available, global outbreaks of viral pathogens such as the virus responsible for the COVID-19 pandemic demonstrate that there is still a critical need for new approaches that can be used to interrupt the chain of viral infection and mitigate virus-associated pathogenesis. Recent studies point to non-thermal plasma (NTP), a partly ionized gas comprised of a complex mixture of reactive oxygen and nitrogen species along with physical effectors, as the potential foundation for new antiviral approaches. A more thorough understanding of the antiviral properties and safety of NTP has stimulated explorations of NTP as the basis for treatments of viral diseases. The recently described immunomodulatory properties of NTP are also being evaluated for potential use in immunotherapies of viral diseases as well as in antiviral vaccination strategies. In this review, we present the current state-of-the-art in addition to compelling arguments that NTP merits further exploration for use in the prevention and management of viral infections and associated diseases.